Trial NCT02702960

View at ClinicalTrials.gov 
Org. Study IDs: J15171
Secondary IDs: IRB00080373

Last trial update was posted on 2018-06-15

MeSH Interventions

Antilymphocyte Serum Cyclophosphamide Fludarabine Mesna Mycophenolic Acid Prednisone Tacrolimus

MeSH Conditions

Carcinoma Carcinoma, Hepatocellular

Other Conditions

Fibrolamellar Hepatocellular Carcinoma Hepatocellular Carcinoma Hepatocellular Carcinoma (Fibrolamellar Variant)

Stopping Reasons

This study was withdrawn due to lack of necessary resources from the liver transplant surgical group.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID